Condensed Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Proceeds on account of shares	Accumulated deficit	Total
Balance at Dec. 31, 2019	$ 39,232	$ (39,205)	$ 106,000	$ (859,230)	$ (753,203)
Balance (in Shares) at Dec. 31, 2019	39,232,570
Proceeds on account of shares			96,362		96,362
Comprehensive loss for the period				(393,265)	(393,265)
Balance at Mar. 31, 2020	$ 39,232	(39,205)	202,362	(1,252,495)	(1,050,106)
Balance (in Shares) at Mar. 31, 2020	39,232,570
Proceeds on account of shares			27,000		27,000
Comprehensive loss for the period				(33,186)	(33,186)
Balance at Jun. 30, 2020	$ 39,232	(39,205)	229,362	(1,285,681)	(1,056,292)
Balance (in Shares) at Jun. 30, 2020	39,232,570
Proceeds on account of shares			9,000		9,000
Comprehensive loss for the period				(25,416)	(25,416)
Balance at Sep. 30, 2020	$ 39,232	(39,205)	238,362	(1,311,097)	(1,072,708)
Balance (in Shares) at Sep. 30, 2020	39,232,570
Balance at Dec. 31, 2020	$ 39,232	(39,205)	238,362	(1,551,660)	(1,313,271)
Balance (in Shares) at Dec. 31, 2020	39,232,570
Proceeds on account of shares			47,563		47,563
Comprehensive loss for the period				(104,070)	(104,070)
Balance at Mar. 31, 2021	$ 39,232	(39,205)	285,925	(1,655,730)	(1,369,778)
Balance (in Shares) at Mar. 31, 2021	39,232,570
Proceeds on account of shares			90,000		90,000
Comprehensive loss for the period				(187,886)	(187,886)
Balance at Jun. 30, 2021	$ 39,232	(39,205)	375,925	(1,843,616)	(1,467,664)
Balance (in Shares) at Jun. 30, 2021	39,232,570
Proceeds on account of shares			1,788,783		1,788,783
Effect of reverse capitalization	$ 24,044	(441,376)			(417,332)
Effect of reverse capitalization (in Shares)	24,044,000
Issuance of shares	$ 1,830	374,095	(375,925)
Issuance of shares (in Shares)	1,829,670
Comprehensive loss for the period				(1,012,471)	(1,012,471)
Balance at Sep. 30, 2021	$ 65,106	$ (106,486)	$ 1,788,783	$ (2,856,087)	$ (1,108,684)
Balance (in Shares) at Sep. 30, 2021	65,106,240